Silverarc Capital Management’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-49,990
Closed -$4.5K 109
2022
Q4
$4.5K Hold
49,990
﹤0.01% 90
2022
Q3
$1K Hold
49,990
﹤0.01% 79
2022
Q2
$9K Hold
49,990
﹤0.01% 69
2022
Q1
$21 Hold
49,990
0.01% 69
2021
Q4
$36K Hold
49,990
0.01% 71
2021
Q3
$35K Hold
49,990
0.02% 82
2021
Q2
$50 Buy
+49,990
New +$39.6K 0.02% 96

Silverarc Capital Management's MSACW Position: Q1 2023 in Review

Silverarc Capital Management sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 49,990 shares — an estimated $4.5K sold.

Silverarc Capital Management first reported a position in MSACW in Q2 2021 and held it in 7 quarters. The position peaked at $36K in Q4 2021. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

  • Silverarc Capital Management reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Silverarc Capital Management sold 49,990 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $4.5K.
  • Silverarc Capital Management first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
  • Silverarc Capital Management's Medicus Sciences Acquisition Corp. Warrant position peaked at $36K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Silverarc Capital Management's 13F filing for Q1 2023, filed 15 May 2023.